Convalescent plasma therapy in patients with COVID ‐19

Author:

Yiğenoğlu Tuğçe Nur1ORCID,Hacıbekiroğlu Tuba2,Berber İlhami3,Dal Mehmet Sinan1,Baştürk Abdülkadir4,Namdaroğlu Sinem5,Korkmaz Serdal6,Ulas Turgay7,Dal Tuba8,Erkurt Mehmet Ali3,Turgut Burhan9,Altuntaş Fevzi110

Affiliation:

1. Ankara Oncology Training and Research Hospital, Department of Hematology and Bone Marrow Transplantation Center University of Health Sciences Ankara Turkey

2. School of Medicine, Department of Internal Medicine, Division of Hematology Sakarya University Sakarya Turkey

3. School of Medicine, Department of Internal Medicine, Division of Hematology Inonu University Malatya Turkey

4. School of Medicine, Department of Internal Medicine, Division of Hematology Selcuk University Konya Turkey

5. Bozyaka Training and Research Hospital, Department of Hematology University of Health Sciences Izmir Turkey

6. Kayseri Training and Research Hospital, Department of Hematology University of Health Sciences Kayseri Turkey

7. School of Medicine, Department of Internal Medicine, Division of Hematology Near East University Nicosia Cyprus

8. School of Medicine, Department of Clinical Microbiology Ankara Yıldırım Beyazıt University Ankara Turkey

9. School of Medicine, Department of Internal Medicine, Division of Hematology Namık Kemal University Tekirdağ Turkey

10. School of Medicine, Department of Internal Medicine, Division of Hematology Ankara Yıldırım Beyazıt University Ankara Turkey

Publisher

Wiley

Subject

Hematology,General Medicine

Reference40 articles.

1. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia

2. A Novel Coronavirus from Patients with Pneumonia in China, 2019

3. World Health Organization Press Conference. The World Health Organization (WHO) has officially named the disease caused by the novel coronavirus as COVID‐19.https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed on April 17 2020.

4. Severe acute respiratory syndrome‐related coronavirus: the species and its viruses ‐ a statement of the Coronavirus Study Group;Gorbalenya AE;bioRxiv,2020

5. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis

Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3